The introduction of AGTR1 knockdown reversed the promotion effect of miR-140-3p inhibitor on the activation of MEK/ERK/STAT3 pathway in ovarian cancer cells, indicating the loss of AGTR1 expression can result in the inhibition of ovarian cancer progression. This evidence concerns the gene MAP2K7 and ovarian cancer.